Page 210 - Remedial Andrology

818. Tang, W., et al. [Clinical efficacy of Viagra with behavior therapy against premature ejaculation].
Zhonghua Nan Ke Xue, 2004. 10: 366.
https://pubmed.ncbi.nlm.nih.gov/15190831
819. McMahon, C.G., et al. Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of
premature ejaculation: a systematic review. BJU Int, 2006. 98: 259.
https://pubmed.ncbi.nlm.nih.gov/16879663
820. Wang, W.F., et al. Phosphodiesterase 5 inhibitors in the treatment of premature ejaculation. Int
J Androl, 2006. 29: 503.
https://pubmed.ncbi.nlm.nih.gov/16573707
821. Zhang, X., et al. Phosphodiesterase-5 Inhibitors for Premature Ejaculation: Systematic Review and
Meta-Analysis of Placebo-Controlled Trials. Am J Mens Health, 2020. 14: 1557988320916406.
https://pubmed.ncbi.nlm.nih.gov/32375542
822. Bai, Y., et al. - Selective Serotonin Reuptake Inhibitors Plus Phosphodiesterase-5 Inhibitors for
Premature Ejaculation: A Systematic Review and Meta-analysis. Urology, 2015. 86: 758.
https://pubmed.ncbi.nlm.nih.gov/26247816
823. Moudi, E., et al. - Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the
Treatment of Premature Ejaculation. Nephrourology Monthly. 8(1):e32286, 2016 Jan., 2016.
https://pubmed.ncbi.nlm.nih.gov/26981497
824. Sun, Y., et al. - Efficacy of Phosphodiesterase-5 Inhibitor in Men With Premature Ejaculation: A New
Systematic Review and Meta-analysis. [Review]. Urology. 86(5):947 54, 2015 Nov., 2015.
https://pubmed.ncbi.nlm.nih.gov/29129027
825. Men, C., et al. Efficacy and safety of phosphodiesterase type 5 inhibitors on primary premature
ejaculation in men receiving selective serotonin reuptake inhibitors therapy: a systematic review and
meta-analysis. Andrologia, 2016. 48: 978.
https://pubmed.ncbi.nlm.nih.gov/26791333
826. Martyn-St James, M., et al. Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A
Systematic Review and Meta-analysis. Eur Urol Focus, 2017. 3: 119.
https://pubmed.ncbi.nlm.nih.gov/28720356
827. Bhat, G.S., et al. Effectiveness of ‘on demand’ silodosin in the treatment of premature ejaculation in
patients dissatisfied with dapoxetine: a randomized control study. Cent European J Urol, 2016. 69: 280.
https://pubmed.ncbi.nlm.nih.gov/27729995
828. Sato, Y., et al. Silodosin versus naftopidil in the treatment of premature ejaculation: A prospective
multicenter trial. Int J Urol, 2017. 24: 626.
https://pubmed.ncbi.nlm.nih.gov/28627033
829. Sato, Y., et al. Silodosin and its potential for treating premature ejaculation: a preliminary report. Int
J Urol, 2012. 19: 268.
https://pubmed.ncbi.nlm.nih.gov/22188258
830. Tuken, M., et al. On-demand Modafinil Improves Ejaculation Time and Patient-reported Outcomes in
Men With Lifelong Premature Ejaculation. Urology, 2016. 94: 139.
https://pubmed.ncbi.nlm.nih.gov/27151339
831. Sahin, S., et al. A Prospective Randomized Controlled Study to Compare Acupuncture and
Dapoxetine for the Treatment of Premature Ejaculation. Urol Int, 2016. 97: 104.
https://pubmed.ncbi.nlm.nih.gov/27049323
832. Kim, J.J., et al. Effects of glans penis augmentation using hyaluronic acid gel for premature
ejaculation. Int J Impot Res, 2004. 16: 547.
https://pubmed.ncbi.nlm.nih.gov/15057258
833. Kwak, T.I., et al. Long-term effects of glans penis augmentation using injectable hyaluronic acid gel
for premature ejaculation. Int J Impot Res, 2008. 20: 425.
https://pubmed.ncbi.nlm.nih.gov/18548080
834. Abdallah, H., et al. Treatment of premature ejaculation by glans penis augmentation using hyaluronic
acid gel: a pilot study. Andrologia, 2012. 44 Suppl 1: 650.
https://pubmed.ncbi.nlm.nih.gov/22013959
835. Alahwany, A., et al. Hyaluronic acid injection in glans penis for treatment of premature ejaculation: a
randomized controlled cross-over study. Int J Impot Res, 2019.
https://pubmed.ncbi.nlm.nih.gov/30610210
836. Ahn, S.T., et al. Complications of glans penis augmentation. Int J Impot Res, 2019. 31: 245.
https://pubmed.ncbi.nlm.nih.gov/30478264
837. Clement, P., et al. Inhibition of ejaculation by the non-peptide oxytocin receptor antagonist
GSK557296: a multi-level site of action. Br J Pharmacol, 2013. 169: 1477.
https://pubmed.ncbi.nlm.nih.gov/23530818

SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021 209